(Q53571709)

English

Isoliquiritigenin (ISL) inhibits ErbB3 signaling in prostate cancer cells.

scientific article published in January 2006

Statements

Isoliquiritigenin (ISL) inhibits ErbB3 signaling in prostate cancer cells. (English)

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit